Variant transthyretin amyloidosis (ATTRv) is an infiltrative multisystem disorder caused by mutations in the transthyretin (TTR) gene, presenting with cardiac, neurological, or mixed phenotypes. As disease awareness increases, the number of identified mutation carriers is expected to rise. Early diagnosis os ATTRv enables family screening and identification of individuals with subclinical involvement, thereby facilitating the initiation of disease-modifying therapies.
Left atrial strain identifies early cardiac involvement in variant transthyretin amyloidosis
Serenelli, Matteo;Cantone, Anna;Pavasini, Rita;Arzenton, Matteo;Campo, Gianluca;
2026
Abstract
Variant transthyretin amyloidosis (ATTRv) is an infiltrative multisystem disorder caused by mutations in the transthyretin (TTR) gene, presenting with cardiac, neurological, or mixed phenotypes. As disease awareness increases, the number of identified mutation carriers is expected to rise. Early diagnosis os ATTRv enables family screening and identification of individuals with subclinical involvement, thereby facilitating the initiation of disease-modifying therapies.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


